BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahluwalia B, Moraes L, Magnusson MK, Öhman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol 2018;53:379-89. [PMID: 29523023 DOI: 10.1080/00365521.2018.1447597] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang M, Yang D, Yu H, Li Q. MicroRNA-497 inhibits inflammation in DSS-induced IBD model mice and lipopolysaccharide-induced RAW264.7 cells via Wnt/β-catenin pathway. Int Immunopharmacol 2021;101:108318. [PMID: 34775365 DOI: 10.1016/j.intimp.2021.108318] [Reference Citation Analysis]
2 Ryma T, Samer A, Soufli I, Rafa H, Touil-boukoffa C. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs). Gastroenterology Insights 2021;12:56-66. [DOI: 10.3390/gastroent12010006] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lee JI, Park KS, Cho IH. Panax ginseng: a candidate herbal medicine for autoimmune disease. J Ginseng Res 2019;43:342-8. [PMID: 31308804 DOI: 10.1016/j.jgr.2018.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
4 Pistol GC, Marin DE, Rotar MC, Ropota M, Taranu I. Bioactive compounds from dietary whole grape seed meal improved colonic inflammation via inhibition of MAPKs and NF-kB signaling in pigs with DSS induced colitis. Journal of Functional Foods 2020;66:103708. [DOI: 10.1016/j.jff.2019.103708] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
5 Nigam GB, Limdi JK. An update on the role of anti-IL-12/IL23 agents in the management of inflammatory bowel disease. Br Med Bull 2021;138:29-40. [PMID: 33884410 DOI: 10.1093/bmb/ldab001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Larabi A, Barnich N, Nguyen HTT. Emerging Role of Exosomes in Diagnosis and Treatment of Infectious and Inflammatory Bowel Diseases. Cells. 2020;9. [PMID: 32365813 DOI: 10.3390/cells9051111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
8 Caviglia GP, Ribaldone DG, Nicolosi A, Pellicano R. Cytokines and Biologic Therapy in Patients with Inflammatory Bowel Diseases. Gastroenterology Insights 2021;12:443-5. [DOI: 10.3390/gastroent12040042] [Reference Citation Analysis]
9 Kostoff RN, Briggs MB, Shores DR. Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation. World J Gastroenterol 2020; 26(33): 4889-4899 [PMID: 32952337 DOI: 10.3748/wjg.v26.i33.4889] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 El-Mahdy NA, El-Sayad ME, El-Kadem AH, Abu-Risha SE. Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis. Fundam Clin Pharmacol 2021;35:143-55. [PMID: 32383169 DOI: 10.1111/fcp.12563] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Antonioli L, Pellegrini C, Fornai M, Benvenuti L, D'Antongiovanni V, Colucci R, Bertani L, Di Salvo C, Semeghini G, La Motta C, Giusti L, Zallocco L, Ronci M, Quattrini L, Angelucci F, Coviello V, Oh WK, Ha QTK, Németh ZH, Haskó G, Blandizzi C. Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation. Int J Mol Sci 2021;22:6325. [PMID: 34199160 DOI: 10.3390/ijms22126325] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Huang M, Jiang W, Luo C, Yang M, Ren Y. Atractylenolide III inhibits epithelial‑mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway. Mol Med Rep 2022;25:98. [PMID: 35088892 DOI: 10.3892/mmr.2022.12614] [Reference Citation Analysis]
13 Guan Q, Warrington R, Moreno S, Qing G, Weiss C, Peng Z. Sustained suppression of IL-18 by employing a vaccine ameliorates intestinal inflammation in TNBS-induced murine colitis. Future Sci OA 2019;5:FSO405. [PMID: 31428451 DOI: 10.2144/fsoa-2018-0125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Mateus V, Estarreja J, Silva I, Barracosa P, Teixeira-lemos E, Pinto R. Effect of Cynara cardunculus L. var. altilis (DC) in Inflammatory Bowel Disease. Applied Sciences 2021;11:1629. [DOI: 10.3390/app11041629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Yang Q, Wang Y, Jia A, Wang Y, Bi Y, Liu G. The crosstalk between gut bacteria and host immunity in intestinal inflammation. J Cell Physiol 2021;236:2239-54. [PMID: 32853458 DOI: 10.1002/jcp.30024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Chen P, Zhu H, Mao Y, Zhuo M, Yu Y, Chen M, Zhao Q, Li L, Wu M, Ye M. SETD8 involved in the progression of inflammatory bowel disease via epigenetically regulating p62 expression. J Gastroenterol Hepatol 2021. [PMID: 33991018 DOI: 10.1111/jgh.15550] [Reference Citation Analysis]
17 Araruna ME, Serafim C, Alves Júnior E, Hiruma-Lima C, Diniz M, Batista L. Intestinal Anti-Inflammatory Activity of Terpenes in Experimental Models (2010-2020): A Review. Molecules 2020;25:E5430. [PMID: 33233487 DOI: 10.3390/molecules25225430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Krueger JG, McInnes IB, Blauvelt A. Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis. J Am Acad Dermatol 2021:S0190-9622(21)02017-X. [PMID: 34224773 DOI: 10.1016/j.jaad.2021.06.869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
19 Chaudhary CL, Gurung P, Jang S, Banskota S, Nam TG, Kim JA, Jeong BS. Synthesis, activity and mechanism of alkoxy-, carbamato-, sulfonamido-, thioureido-, and ureido-derivatives of 2,4,5-trimethylpyridin-3-ol against inflammatory bowel disease. J Enzyme Inhib Med Chem 2020;35:1-20. [PMID: 31619080 DOI: 10.1080/14756366.2019.1677637] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Hossian AKMN, Mackenzie GG, Mattheolabakis G. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally? Nanomedicine (Lond) 2019;14:2873-89. [PMID: 31735124 DOI: 10.2217/nnm-2019-0180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Samimi N, Sepehrimanesh M, Koohi-Hosseinabadi O, Homayounfar R, Mokhtari M, Farjam M. The Therapeutic Effect of Shark Liver Oil in a Rat Model of Acetic Acid-Induced Ulcerative Colitis. Evid Based Complement Alternat Med 2020;2020:2419230. [PMID: 33149751 DOI: 10.1155/2020/2419230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Vardavas AI, Porter AL. Common contributing factors to COVID-19 and inflammatory bowel disease. Toxicol Rep 2021;8:1616-37. [PMID: 34485092 DOI: 10.1016/j.toxrep.2021.08.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Astó E, Méndez I, Audivert S, Farran-Codina A, Espadaler J. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.Nutrients. 2019;11. [PMID: 30704039 DOI: 10.3390/nu11020293] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 13.3] [Reference Citation Analysis]
24 Nardone OM, Shivaji UN, Ferruzza V, Ghosh S, Iacucci M. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. Inflamm Bowel Dis 2020;26:961-9. [PMID: 31587036 DOI: 10.1093/ibd/izz226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
25 Borg-Bartolo SP, Boyapati RK, Satsangi J, Kalla R. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res. 2020;9. [PMID: 32047622 DOI: 10.12688/f1000research.20928.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
26 Quah Y, Park NH, Lee EB, Lee KJ, Yi-Le JC, Ali MS, Jang SH, Kim MJ, Lee SJ, Park SC. Trifolium pratense ethanolic extract alters the gut microbiota composition and regulates serum lipid profile in the ovariectomized rats. BMC Complement Med Ther 2022;22:5. [PMID: 34983484 DOI: 10.1186/s12906-021-03486-w] [Reference Citation Analysis]
27 Qian J, Lu J, Huang Y, Wang M, Chen B, Bao J, Wang L, Cui D, Luo B, Yan F. Periodontitis Salivary Microbiota Worsens Colitis. J Dent Res 2021;:220345211049781. [PMID: 34796773 DOI: 10.1177/00220345211049781] [Reference Citation Analysis]
28 Anka Idrissi D, Senhaji N, Aouiss A, Khalki L, Tijani Y, Zaid N, Marhoume FZ, Naya A, Oudghiri M, Kabine M, Zaid Y. IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets. Arch Pharm Res 2021;44:117-32. [PMID: 33394309 DOI: 10.1007/s12272-020-01296-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Nourbakhsh E, Mohammadi A, Salemizadeh Parizi M, Mansouri A, Ebrahimzadeh F. Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target. Inflammopharmacology 2021. [PMID: 34283371 DOI: 10.1007/s10787-021-00846-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Traylor-Knowles N, Vandepas LE, Browne WE. Still Enigmatic: Innate Immunity in the Ctenophore Mnemiopsis leidyi. Integr Comp Biol 2019;59:811-8. [PMID: 31251332 DOI: 10.1093/icb/icz116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
31 Mishima Y, Sartor RB. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases. J Gastroenterol 2020;55:4-14. [PMID: 31482438 DOI: 10.1007/s00535-019-01618-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
32 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
33 Bertani L, Antonioli L, Fornai M, Tapete G, Baiano Svizzero G, Marchi S, Blandizzi C, Costa F. Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases. Minerva Gastroenterol Dietol 2019;65:298-308. [PMID: 31646851 DOI: 10.23736/S1121-421X.19.02621-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
34 Danese S, Peyrin-Biroulet L. Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise. Inflamm Bowel Dis 2021:izab135. [PMID: 34089259 DOI: 10.1093/ibd/izab135] [Reference Citation Analysis]
35 Jiang Y, Zhao L, Chen Q, Zhou L. Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology. Evid Based Complement Alternat Med 2021;2021:9970240. [PMID: 34211579 DOI: 10.1155/2021/9970240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Minakshi P, Kumar R, Ghosh M, Brar B, Barnela M, Lakhani P. Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Curr Top Med Chem 2020;20:982-1008. [PMID: 32196449 DOI: 10.2174/1568026620666200320113322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
37 Toskas A, Akbar A. IBD therapeutics: what is in the pipeline? Frontline Gastroenterol 2022;13:e35-43. [DOI: 10.1136/flgastro-2022-102130] [Reference Citation Analysis]
38 Rueda Ruzafa L, Cedillo JL, Hone AJ. Nicotinic Acetylcholine Receptor Involvement in Inflammatory Bowel Disease and Interactions with Gut Microbiota. Int J Environ Res Public Health 2021;18:1189. [PMID: 33572734 DOI: 10.3390/ijerph18031189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Swanson KD, Theodorou E, Kokkotou E. Reproducing the human mucosal environment ex vivo: inflammatory bowel disease as a paradigm. Curr Opin Gastroenterol 2018;34:384-91. [PMID: 30188406 DOI: 10.1097/MOG.0000000000000485] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Huangfu S, Dou R, Zhong S, Guo M, Gu C, Jurczyszyn A, Yang Y, Jiang B. Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6/STAT3 pathway. BMC Complement Med Ther 2020;20:179. [PMID: 32517784 DOI: 10.1186/s12906-020-02974-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
41 Nasonov EL, Abdulganieva DI, Fairushina IF. The use of Tofacitinib in the treatment of inflammatory bowel disease. Ter Arkh 2019;91:101-8. [PMID: 31094180 DOI: 10.26442/00403660.2019.02.000155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
42 Schulte L, Hohwieler M, Müller M, Klaus J. Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease. Stem Cells Int 2019;2019:8010645. [PMID: 31015842 DOI: 10.1155/2019/8010645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Rodrigues VF, Camelo GMA, de Rezende MC, Maggi L, Silva JKAO, Rodrigues JGM, Araújo MSS, Martins-Filho OA, Negrão-Corrêa D. Infection by Strongyloides venezuelensis attenuates chronic colitis induced by Dextran Sodium Sulfate ingestion in BALB/c mice. Immunobiology 2021;226:152129. [PMID: 34433129 DOI: 10.1016/j.imbio.2021.152129] [Reference Citation Analysis]
44 Chulkina M, Beswick EJ, Pinchuk IV. Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation. Int J Mol Sci 2020;21:E9165. [PMID: 33271941 DOI: 10.3390/ijms21239165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Alberti G, Mazzola M, Gagliardo C, Pitruzzella A, Fucarini A, Giammanco M, Tomasello G, Carini F. Extracellular vesicles derived from gut microbiota in inflammatory bowel disease and colorectal cancer: new players? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34282804 DOI: 10.5507/bp.2021.042] [Reference Citation Analysis]
46 Valdez JC, Cho J, Bolling BW. Aronia berry inhibits disruption of Caco-2 intestinal barrier function. Archives of Biochemistry and Biophysics 2020;688:108409. [DOI: 10.1016/j.abb.2020.108409] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
47 Holmes EA, Rodney Harris RM, Lucas RM. Low Sun Exposure and Vitamin D Deficiency as Risk Factors for Inflammatory Bowel Disease, With a Focus on Childhood Onset. Photochem Photobiol 2019;95:105-18. [PMID: 30155900 DOI: 10.1111/php.13007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
48 Kikut J, Mokrzycka M, Drozd A, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC). JCM 2022;11:1861. [DOI: 10.3390/jcm11071861] [Reference Citation Analysis]
49 Grigas J, Montoya M, Simkute E, Buitkus M, Zagrabskaite R, Pautienius A, Razukevicius D, Jonaitis LV, Kiudelis G, Skieceviciene J, Vaiciuniene R, Stankuviene A, Bumblyte IA, Kupcinskas J, Stankevicius A. Molecular Characterization and Seroprevalence of Hepatitis E Virus in Inflammatory Bowel Disease Patients and Solid Organ Transplant Recipients. Viruses 2021;13:670. [PMID: 33924409 DOI: 10.3390/v13040670] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Takač B, Mihaljević S, Glavaš-Obrovac L, Kibel A, Suver-Stević M, Canecki-Varžić S, Samardžija M, Rajkovac I, Kovač D, Štefanić M. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS. Acta Clin Croat 2020;59:67-80. [PMID: 32724277 DOI: 10.20471/acc.2020.59.01.09] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Ghattamaneni NKR, Brown L. Functional foods from the tropics to relieve chronic normobaric hypoxia. Respir Physiol Neurobiol 2021;286:103599. [PMID: 33333240 DOI: 10.1016/j.resp.2020.103599] [Reference Citation Analysis]
52 Keshteli AH, Madsen KL, Dieleman LA. Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions. Nutrients 2019;11:E1498. [PMID: 31262022 DOI: 10.3390/nu11071498] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
53 Huyben D, Vidakovic A, Sundh H, Sundell K, Kiessling A, Lundh T. Haematological and intestinal health parameters of rainbow trout are influenced by dietary live yeast and increased water temperature. Fish Shellfish Immunol 2019;89:525-36. [PMID: 30999040 DOI: 10.1016/j.fsi.2019.04.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
54 Graham JJ, Longhi MS, Heneghan MA. T helper cell immunity in pregnancy and influence on autoimmune disease progression. J Autoimmun 2021;121:102651. [PMID: 34020252 DOI: 10.1016/j.jaut.2021.102651] [Reference Citation Analysis]
55 Mohammad Jafari R, Shayesteh S, Ala M, Yousefi-Manesh H, Rashidian A, Hashemian SM, Sorouri M, Dehpour AR. Dapsone Ameliorates Colitis through TLR4/NF-kB Pathway in TNBS Induced Colitis Model in Rat. Arch Med Res 2021;52:595-602. [PMID: 33814208 DOI: 10.1016/j.arcmed.2021.03.005] [Reference Citation Analysis]
56 Abbasi-Kenarsari H, Heidari N, Baghaei K, Amani D, Zali MR, Gaffari Khaligh S, Shafiee A, Hashemi SM. Synergistic therapeutic effect of mesenchymal stem cells and tolerogenic dendritic cells in an acute colitis mouse model. Int Immunopharmacol 2020;88:107006. [PMID: 33182049 DOI: 10.1016/j.intimp.2020.107006] [Reference Citation Analysis]
57 Baradaran Ghavami S, Asadzadeh Aghdaei H, Sorrentino D, Shahrokh S, Farmani M, Ashrafian F, Dore MP, Keshavarz Azizi Raftar S, Mobin Khoramjoo S, Zali MR. Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease? Int J Mol Sci 2021;22:8274. [PMID: 34361038 DOI: 10.3390/ijms22158274] [Reference Citation Analysis]
58 Caviglia GP, Rosso C, Stalla F, Rizzo M, Massano A, Abate ML, Olivero A, Armandi A, Vanni E, Younes R, Fagoonee S, Pellicano R, Astegiano M, Saracco GM, Bugianesi E, Ribaldone DG. On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. J Clin Med 2020;9:E800. [PMID: 32183476 DOI: 10.3390/jcm9030800] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
59 Kostik MM, Makhova MA, Maletin AS, Magomedova SM, Sorokina LS, Tsukasaki M, Okamoto K, Takayanagi H, Vasiliev DS, Kozlova DI, Mushkin AY. Cytokine profile in patients with chronic non-bacterial osteomyelitis, juvenile idiopathic arthritis, and insulin-dependent diabetes mellitus. Cytokine 2021;143:155521. [PMID: 33863633 DOI: 10.1016/j.cyto.2021.155521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Gracey E, Dumas E, Yerushalmi M, Qaiyum Z, Inman RD, Elewaut D. The ties that bind: skin, gut and spondyloarthritis. Curr Opin Rheumatol 2019;31:62-9. [PMID: 30407224 DOI: 10.1097/BOR.0000000000000569] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
61 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Bernard Q, Hu LT. Innate Immune Memory to Repeated Borrelia burgdorferi Exposure Correlates with Murine In Vivo Inflammatory Phenotypes. J Immunol 2020;205:3383-9. [PMID: 33168577 DOI: 10.4049/jimmunol.2000686] [Reference Citation Analysis]
63 Suri K, Bubier JA, Wiles MV, Shultz LD, Amiji MM, Hosur V. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021;10:2204. [PMID: 34571853 DOI: 10.3390/cells10092204] [Reference Citation Analysis]